Drugs / TS-2021
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06585527 | Aug 2024 → Jan 2026 overdue | glioblastoma | Beijing Neurosurgical Institute | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TS-2021 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06585527 ↗ |
| Route | Other | “intratumoral injection” NCT06585527 ↗ |